Display Settings:

Format

Send to:

Choose Destination

    Drugs Today (Barc). 2006 Jan;42(1):65-70.

    Fabry disease.

    Levin M.

    Department of Hematology and Oncology, University Hospital of New Jersey Medical School, Newark, New Jersey 07101, USA. mlevinmd@aol.com

    Republished in:

    Fabry disease is an inherited enzyme deficiency of galactosidase A that results in various phenotypes: classic, cardiac or renal. It can present variably and may represent an important cause of occult neurological and cardiac syndromes and renal failure. Preclinical and clinical studies demonstrate effectiveness of enzyme infusion in controlling and preventing these manifestations of the disease. Copyright 2006 Prous Science

    PMID: 16511611 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read